A Study of GPC3 Redirected Autologous T Cells for Advanced HCC
Clinical trial NCT02715362 · UNKNOWN
Trial details
- NCT number
- NCT02715362
- Sponsor
- Shanghai GeneChem Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.